Get started
ASPEN PHARMACARE HLDGS LTDASPEN PHARMACARE HLDGS LTDASPEN PHARMACARE HLDGS LTD

ASPEN PHARMACARE HLDGS LTD

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

APN chart


Full chart

APN upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪77.20 B‬ ZAR
Dividend yield (indicated)
2.07%
Price to earnings Ratio (TTM)
17
Basic EPS (TTM)
10 ZAR
Net income (FY)
‪4.40 B‬ ZAR
Revenue (FY)
‪44.71 B‬ ZAR
Shares float
‪356.07 M‬
Beta (1Y)
0.69

Employees


Employees (FY)
‪9.35 K‬
Change (1Y)
+189 +2.06%
Revenue / Employee (1Y)
‪4.78 M‬ ZAR
Net income / Employee (1Y)
‪471.02 K‬ ZAR

About ASPEN PHARMACARE HLDGS LTD


Sector
Health Technology
CEO
Stephen Bradley Saad
Headquarters
Durban
Website
aspenpharma.com
Founded
1850
ISIN
ZAE000066692
FIGI
BBG000BP97L3
Aspen Pharmacare Holdings Ltd. manufactures and supplies branded and generic pharmaceutical products. It operates through the Commercial Pharmaceuticals and Manufacturing segments. The Commercial Pharmaceuticals segment consists of the following business sub segments: Sterile Focused Brands, which includes the Anaesthetics and Thrombosis portfolios; and Regional Brands, which are products that are managed on a regional basis. The Manufacturing segment focuses on the following business sub segments: Active Pharmaceutical Ingredients, which involved in API Chemicals business and non-heparin biochemical API business; Heparin, which refers to the full value chain contribution from all heparin containing products; FDF Steriles, which includes all FDF sterile sales; and FDF Other, which consists of all non-sterile FDF products. The company was founded by Michael Guy Attridge and Stephen Bradley Saad in 1850 and is headquartered in Durban, South Africa.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

APN news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of APN is 17,377 ZAC — it has increased by 5.00% in the past 24 hours. Watch ASPEN PHARMACARE HLDGS LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on JSE exchange ASPEN PHARMACARE HLDGS LTD stocks are traded under the ticker APN.
APN stock has risen by 2.71% compared to the previous week, the month change is a 0.72% rise, over the last year ASPEN PHARMACARE HLDGS LTD has showed a −10.33% decrease.
We've gathered analysts' opinions on ASPEN PHARMACARE HLDGS LTD future price: according to them, APN price has a max estimate of 23,500.00 ZAC and a min estimate of 20,100.00 ZAC. Watch APN chart and read a more detailed ASPEN PHARMACARE HLDGS LTD stock forecast: see what analysts think of ASPEN PHARMACARE HLDGS LTD and suggest that you do with its stocks.
APN reached its all-time high on Jan 27, 2015 with the price of 44,868 ZAC, and its all-time low was 629 ZAC and was reached on Mar 17, 2003. View more price dynamics on APN chart.
See other stocks reaching their highest and lowest prices.
APN stock is 6.82% volatile and has beta coefficient of 0.69. Track ASPEN PHARMACARE HLDGS LTD stock price on the chart and check out the list of the most volatile stocks — is ASPEN PHARMACARE HLDGS LTD there?
Today ASPEN PHARMACARE HLDGS LTD has the market capitalization of ‪77.20 B‬, it has increased by 0.20% over the last week.
Yes, you can track ASPEN PHARMACARE HLDGS LTD financials in yearly and quarterly reports right on TradingView.
ASPEN PHARMACARE HLDGS LTD is going to release the next earnings report on Mar 6, 2025. Keep track of upcoming events with our Earnings Calendar.
APN net income for the last half-year is ‪2.09 B‬ ZAR, while the previous report showed ‪2.31 B‬ ZAR of net income which accounts for −9.68% change. Track more ASPEN PHARMACARE HLDGS LTD financial stats to get the full picture.
Yes, APN dividends are paid annually. The last dividend per share was 3.59 ZAR. As of today, Dividend Yield (TTM)% is 2.07%. Tracking ASPEN PHARMACARE HLDGS LTD dividends might help you take more informed decisions.
ASPEN PHARMACARE HLDGS LTD dividend yield was 1.54% in 2024, and payout ratio reached 36.21%. The year before the numbers were 1.86% and 29.06% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 22, 2024, the company has ‪9.35 K‬ employees. See our rating of the largest employees — is ASPEN PHARMACARE HLDGS LTD on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ASPEN PHARMACARE HLDGS LTD EBITDA is ‪11.29 B‬ ZAR, and current EBITDA margin is 23.95%. See more stats in ASPEN PHARMACARE HLDGS LTD financial statements.
Like other stocks, APN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ASPEN PHARMACARE HLDGS LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ASPEN PHARMACARE HLDGS LTD technincal analysis shows the buy rating today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ASPEN PHARMACARE HLDGS LTD stock shows the sell signal. See more of ASPEN PHARMACARE HLDGS LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.